Lack of association of tyrosine hydroxylase genetic polymorphism with cigarette smoking

Pharmacogenetics

Volumn 7, Issue 6, 1997, Pages 521-524

  Lerman, Caryn ^a   Shields, Peter G ^b   Main, David ^a   Audrain, Janet ^a   Roth, Joan ^a   Boyd, Neal R ^c   Caporaso, Neil E ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

Genetics; Hydroxylase; Nicotine; Smoking; Tyrosine

Indexed keywords

NICOTINE; TYROSINE 3 MONOOXYGENASE;

ADULT; AGED; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; SHORT SURVEY; SMOKING;

EID: 0030666918     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199712000-00012     Document Type: Short Survey

References (14)

1. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 1995: 65, 1157-1165.
2. Carmelli D, Swan GE, Robinette D, Fabsitz R. Genetic influence on smoking - a study of male twins. N Engl J Med 1992: 327, 829-833.
3. 2 receptor (DRD2) gene: A genetic risk factor in smoking. Pharmacogenetics 1996: 6, 73-79.
4. Henningfield JE, Schuh LM, Jarvik ME. Pathophysiology of tobacco dependence. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The fourth generation of progress. New York: Raven Press, 1995: 1715-1730.
5. Hiremagalur B, Nankova B, Nitahara J, Zeman R, Sabban FL. Nicotine increases expression of tyrosine hydroxylase gene. Involvement of protein kinase A-mediated pathway. J Biol Chem 1993: 268, 23704-25711.
6. Javoy-Agid F, Hirsch EC, Dumas S, Duyckaerts C, Mallet J, Agid Y. Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: An in situ hybridization study. Neuroscience 1990: 38, 245-253.
7. Körner J, Rietschel M, Hunt N, Castle D. Gill M, Nöthen MM, Craddock N, Daniels J, Owen M, Fimmers R et al. Association and haplotype analysis at the tyrosine hydroxylase locus in a combined German-British sample of manic depressive patients and controls. Psychiatr Genet 1994: 4, 167-175.
8. Lerman C, Audrain J, Orleans CT, Boyd NR, Gold K, Main D, Caporaso N. Investigation of mechanisms linking depressed mood to nicotine dependence. Addict Behav 1996: 21, 9-19.
9. Nabeshima T, Itoh A, Kobayashi K, Morita S, Mizuguchi T, Sawada H, Nitta A, Hasegawa T, Hayashi K, Nagatsu T. Effects of subacute administration of methamphetamine and nicotine on locomotor activity in transgenic mice expressing the human tyrosine hydroxylase gene. J Neural Transm Gen Sect 1994: 97, 41-49.
10. Newhouse PA, Hughes JR. The role of nicotine and nicotinic mechanisms in neuropsychiatrie disease. Br J Addict 1991: 86, 521-526.
11. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. Allelic association of the D2 dopamine receptor gene with receptor binding characteristics in alcoholism. Arch Gen Psychiatry 1491: 48, 648-654.
12. O'Malley KL, Anhalt MJ, Martin BM, Kelsoe JR. Winfield SL. Ginns EL. Isolation and characterization of the human tyrosine hydroxylase gene: Identification of 5′ alternative splice sites responsible tor multiple mRNAs. Biochemistry 1987: 26, 2910-2914.
13. Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Tetranucleotide repeal polymorphism at the human tyrosine hydroxylase gene (TH). Nucleic Acids Res 1991: 19, 3753.
14. Todd RD, O'Malley KL. Population frequencies of tyrosine hydroxylase restriction fragment length polymorphisms in bipolar affective disorder. Biol Psychiatry 1989: 25, 626-630.